Citation Impact
Citing Papers
Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]
2011
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018
Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial
2003
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Dietary Fiber, Glycemic Load, and Risk of Non—insulin-dependent Diabetes Mellitus in Women
1997 Standout
Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy
2000
Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension
2002
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Exploring the characteristics of suboptimally controlled patients after 24 weeks of basal insulin treatment: An individualized approach to intensification
2016
Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial
1999
Tramadol/Acetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study
2003
Changes of lipolytic enzymes cluster with insulin resistance syndrome
1995
The Validity of the Neuropathic Pain Scale for Assessing Diabetic Neuropathic Pain in a Clinical Trial
2005
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
2003
The pathogenesis and management of painful diabetic neuropathy: a review
2003
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
2006
Tramadol in the Treatment of Neuropathic Cancer Pain
2007
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
2012
Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men1
1999
Cardiovascular risk continuum: implications of insulin resistance and diabetes
1998
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
2008
Oral Antihyperglycemic Therapy for Type 2 Diabetes
2002
Diabetes Mellitus and Cardiovascular Disease in Women
1998
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Tramadol in Neuropathic Pain After Spinal Cord Injury
2009
Opioide bei chronischem neuropathischem Schmerz
2014
EFNS guidelines on pharmacological treatment of neuropathic pain
2006
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
2017
The Link Between Insulin Resistance and Hypertension
1994
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial
2003
Disordered metabolism in diabetes: Have we underemphasized the fat component?
1994
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy
2006
Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies
2004
Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species
2007
Type 2 diabetes
2017 Standout
Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial
2003
Diabetes and Atherosclerosis
2002 Standout
Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury
2001
Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials
2004
Diabetic neuropathy: clinical manifestations and current treatments
2012
Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Response Profile
2007
Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial
1999
Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial
2001
Treatment of Postherpetic Neuralgia
2000
Generalized lipodystrophy, congenital and acquired (lipoatrophy)
1996
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
2015
A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain
2011
Painful Sensory Neuropathy
2003
High Fat Diet‐Induced Insulin Resistance
1993
Prolonged‐release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients
2008
Treatment of symptomatic diabetic neuropathy
2003
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
The use of complementary and alternative medicines by patients with peripheral neuropathy
2003
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density
2004 Standout
Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis
2016
Current research activity in biosensors
2003
Tramadol for neuropathic pain
2006
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Clinical Pharmacology of Tramadol
2004 Standout
Evidence‐based guideline: Treatment of painful diabetic neuropathy—report of the american association of neuromuscular and electrodiagnostic medicine, the american academy of neurology, and the american academy of physical medicine & rehabilitation
2011
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
1999 Standout
Low‐intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease
1994
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Telomere shortening occurs in Asian Indian Type 2 diabetic patients
2005
Preventing Foot Ulcers in Patients With Diabetes
2005 Standout
Critical review of oral drug treatments for diabetic neuropathic pain—clinical outcomes based on efficacy and safety data from placebo‐controlled and direct comparative studies
2005
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
2004
Endothelin: emerging role in diabetic vascular complications
1999
Zonisamide in the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2005
A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain
2007
Diabetic neuropathy
2019
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
2021
Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial
2013
Algorithm for neuropathic pain treatment: An evidence based proposal
2005
An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
1995 Standout
Tramadol relieves thermal hyperalgesia in rats with chronic constriction injury of the sciatic nerve
2000
Herpes Zoster
2002 Standout
The importance of titrating starting insulin regimens in patients with type 2 diabetes
2009
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Relationship between insulin resistance and abnormal lipid profile in obese adolescents
1995
Mexiletine
1998
New Insulins and New Aspects in Insulin Delivery
2015
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
High-Performance Capillary Electrophoresis-Pure Creatine Monohydrate Reduces Blood Lipids in Men and Women
1996
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children
2003
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
2005 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance
1999
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
1999 Standout
Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans
2017
New insulins and newer insulin regimens: a review of their role in improving glycaemic control in patients with diabetes
2016
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The Early Natural History of Nephropathy in Type 1 Diabetes
2002
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Methods for reducing biosensor membrane biofouling
2000
Asymptomatic atherosclerosis and insulin resistance.
1991
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Tramadol for neuropathic pain
2004
International Diabetes Center Treatment of Type 2 Diabetes Glucose Algorithm
2011
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice
2017
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
2010
Relation Between Insulin Resistance, Hyperinsulinemia, Postheparin Plasma Lipoprotein Lipase Activity, and Postprandial Lipemia
1995
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
A lightweight measuring device for the continuous in vivo monitoring of glucose by means of ultraslow microdialysis in combination with a miniaturised flow-through biosensor
2002
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Postamputation Pain and Sensory Changes in Treatment-naive Patients
2005
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Lamotrigine reduces painful diabetic neuropathy
2001
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Risk Factor Groupings Related to Insulin Resistance and Their Synergistic Effects on Subclinical Atherosclerosis
2002
Diabetic Somatic Neuropathies
2004 Standout
Long-term opioid management for chronic noncancer pain
2010
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Electrochemical Glucose Biosensors
2007 Standout
Controlled-release oxycodone for pain in diabetic neuropathy
2003
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance.
1990
Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy
1995
Adjust to Target in Type 2 Diabetes
2008
Pharmacologic treatment of pain in polyneuropathy
2000
Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic
2001
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy
2003
Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2017
Creatine and Creatinine Metabolism
2000 Standout
Works of P. Raskin being referenced
Low prevalence of microalbuminuria in normotensive patients with insulin-dependent diabetes mellitus
1991
Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial
2011
Insulin Requirements in Lipodystrophic Diabetes
1993
Lipoprotein (a) Levels in Diabetes Mellitus: Relationship to Metabolic Control
1992
Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)
2007
Cardiovascular risk in diabetes
2000
Initial Evaluation of a 290-μm Diameter Subcutaneous Glucose Sensor
1998
Relationship between lipoprotein levels and in vivo insulin action in normal young white men
1988
Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy
1990
Patient‐directed titration for achieving glycaemic goals using a once‐daily basal insulin analogue: an assessment of two different fasting plasma glucose targets ‐ the TITRATE TM study
2009
Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.
2000
A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
2000
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial ( BEGIN : ADD TO GLP ‐1 S tudy)
2016
The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes
1977
Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
1998